Atossa Genetics Stock Market Value
| ATOS Stock | USD 3.94 0.11 2.72% |
| Symbol | Atossa |
Is there potential for Health Care Equipment & Supplies market expansion? Will Atossa introduce new products? Factors like these will boost the valuation of Atossa Genetics. If investors know Atossa will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Atossa Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Atossa Genetics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Atossa Genetics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Atossa Genetics' market price to deviate significantly from intrinsic value.
Understanding that Atossa Genetics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Atossa Genetics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Atossa Genetics' market price signifies the transaction level at which participants voluntarily complete trades.
Atossa Genetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Atossa Genetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Atossa Genetics.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Atossa Genetics on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Atossa Genetics or generate 0.0% return on investment in Atossa Genetics over 90 days. Atossa Genetics is related to or competes with Oncolytics Biotech, Tevogen Bio, Greenwich Lifesciences, Instil Bio, Immix Biopharma, Whitehawk Therapeutics, and Clene. Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medic... More
Atossa Genetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Atossa Genetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Atossa Genetics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 42.59 | |||
| Value At Risk | (9.93) | |||
| Potential Upside | 6.75 |
Atossa Genetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atossa Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Atossa Genetics' standard deviation. In reality, there are many statistical measures that can use Atossa Genetics historical prices to predict the future Atossa Genetics' volatility.| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (1.54) | |||
| Total Risk Alpha | (2.18) | |||
| Treynor Ratio | (1.61) |
Atossa Genetics February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.18) | |||
| Market Risk Adjusted Performance | (1.60) | |||
| Mean Deviation | 3.85 | |||
| Coefficient Of Variation | (425.51) | |||
| Standard Deviation | 6.15 | |||
| Variance | 37.82 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (1.54) | |||
| Total Risk Alpha | (2.18) | |||
| Treynor Ratio | (1.61) | |||
| Maximum Drawdown | 42.59 | |||
| Value At Risk | (9.93) | |||
| Potential Upside | 6.75 | |||
| Skewness | (2.45) | |||
| Kurtosis | 11.61 |
Atossa Genetics Backtested Returns
Atossa Genetics secures Sharpe Ratio (or Efficiency) of -0.25, which signifies that the company had a -0.25 % return per unit of risk over the last 3 months. Atossa Genetics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Atossa Genetics' Mean Deviation of 3.85, standard deviation of 6.15, and Risk Adjusted Performance of (0.18) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.91, which signifies possible diversification benefits within a given portfolio. Atossa Genetics returns are very sensitive to returns on the market. As the market goes up or down, Atossa Genetics is expected to follow. At this point, Atossa Genetics has a negative expected return of -1.58%. Please make sure to confirm Atossa Genetics' information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Atossa Genetics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.74 |
Good predictability
Atossa Genetics has good predictability. Overlapping area represents the amount of predictability between Atossa Genetics time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Atossa Genetics price movement. The serial correlation of 0.74 indicates that around 74.0% of current Atossa Genetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.74 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 3.31 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.